Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI–2% Glucose

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.44.2.400-404.2000PMID 10639369PMCID PMC89690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved standard-second edition

  2002cited by this paper
• Detection of Resistance to Amphotericin B amongCryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies

  1998influential reference
• Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans

  1996cited by this paper
• Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

  1995cited by this paper
• Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.

  1995cited by this paper
• Oxygen as limiting nutrient for growth of Cryptococcus neoformans

  1995cited by this paper
• Improved medium for fluconazole susceptibility testing of Candida albicans

  1994cited by this paper
• Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

  1994cited by this paper
• Susceptibility testing of Cryptococcus neoformans: a microdilution technique

  1992influential reference
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Modifications of antifungal sensibility testing as suggested by CLSI document M27-A4: proposal for using different culture medium and buffer.

  2021cites this paper
• Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI)

  2020cites this paper
• Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds.

  2018cites this paper
• ANALYSIS OF EXOPOLYSACCHARIDE OF IG-1 (CITROBACTER FREUNDII) ISOLATED FROM EARTHWORM UNDER DIFFERENT PHYSIOLOGICAL CONDITIONS

  2018cites this paper
• Comparison of Different In Vitro Tests to Detect Cryptococcus neoformans Not Susceptible to Amphotericin B

  2015cites this paper
• Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.

  2014cites this paper
• Sinergismo in vitro entre hidrazonas, ajoeno y posaconazol sobre aislados de Cryptococcus spp

  2011cites this paper
• [In vitro synergisms among hydrazones, ajoeno and posaconazole against Cryptococcus spp].

  2011cites this paper
• Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.

  2011cites this paper
• Process Analysis of Variables for Standardization of Antifungal Susceptibility Testing of Nonfermentative Yeasts

  2011cites this paper
• Evaluation of the in vitro activity of amphotericin B by time-kill curve methodology against large and small capsulate C. neoformans isolates.

  2011cites this paper
• Resistance to Antifungal Agents

  2010cites this paper
• Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review.

  2010cites this paper
• Hypoxia sensing in cryptococcus neoformans: biofilm-like adaptation for dormancy?

  2009cites this paper
• Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.

  2009cites this paper
• Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients

  2008cites this paper
• Reliability of the WIDERYST Susceptibility Testing System for Detection of In Vitro Antifungal Resistance in Yeasts

  2008cites this paper
• Procedimientos de diagnóstico microbiológico de las micosis y estudios de sensibilidad a los antifúngicos

  2007cites this paper
• Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.

  2007cites this paper
• Antifungal agents

  2007cites this paper
• Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1.

  2007cites this paper
• [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing].

  2007cites this paper
• AVALIAÇÃO DA CRIPTOCOCOSE EXPERIMENTAL SISTÊMICA EM CAMUNDONGOS BALB/c E TERAPÊUTICA COM ANFOTERICINA B, FLUCONAZOL E ASSOCIAÇÃO.

  2007cites this paper
• Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

  2006cites this paper
• Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.

  2005cites this paper
• Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.

  2005cites this paper
• Natural products and antifungal drug discovery.

  2005cites this paper
• Susceptibility Patterns and Molecular Identification of Trichosporon Species

  2005cites this paper
• Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism

  2004cites this paper
• Genotyping and Antifungal Susceptibility Profile of Dipodascus capitatus Isolates Causing Disseminated Infection in Seven Hematological Patients of a Tertiary Hospital

  2004cites this paper
• OF THE BRAZILIAN EXPERIENCE FOR THE DISEASE

  2004cites this paper
• In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates

  2004cites this paper
• Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia

  2004cites this paper
• G484S Amino Acid Substitution in Lanosterol 14-α Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate

  2003cites this paper
• Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine.

  2003cites this paper
• Cryptococcosis: a review of the Brazilian experience for the disease.

  2003cites this paper
• Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).

  2003cites this paper
• [Pseudozyma sp.: colonizer of the respiratory tract in critical patients].

  2003cites this paper
• Pseudozyma sp.: colonizador de vías respiratorias en enfermos críticos

  2003cites this paper
• In vitro interaction between antifungals and other agents against pathogenic fungi

  2003cites this paper
• Pueden basarse las indicaciones de los antifúngicos en los estudios de

  2002cites this paper
• A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions.

  2002cites this paper
• Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing ofCandida spp

  2001cites this paper
• Flucytosine Primary Resistance in Candida Species and Cryptococcus neoformans

  2001cites this paper
• Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

  2001cites this paper
• Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media

  2001cites this paper
• Present status of the detection of antifungal resistance: the perspective from both sides of the ocean.

  2001cites this paper
• Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

  2001cites this paper